ISAR Webinar Series
The International Society for Antiviral Research invites you to join us for a webinar at 4 PM CST on Thursday, February 27, 2020.
Speaker: Dr. Mark Denison, M.D. Director, Division of Infectious Diseases and Professor of Pathology, Microbiology & Immunology, Vanderbilt University School of Medicine, Nashville, TN
Topic: Targeting antivirals against COVID-19 (SARS-CoV-2) and future zoonotic coronaviruses
The new zoonotic coronavirus is the third in 16 years to cause severe disease across the globe. The disease COVID-19 is caused by the newly designated SARS-CoV-2, which likely emerged from bats, possibly with intermediate hosts, but is now established as a human disease, with a range of severity in over 72,000 cases and 1800 deaths. We have been engaged in preclinical development of remedisivir and other nucleoside analogs for use against SARS-CoV, MERS-CoV and other potential zoonotic CoVs. The webinar will discuss biology of coronaviruses, current antiviral development, and targets for broad-based antivirals.
We will be using GoToWebinar, which is compatible with a Mac, PC or mobile device. To register, go to
Future Speakers to be announced
Previous Webinars can be accessed by ISAR Members on this page
The International Society for Antiviral Research (ISAR) is an internationally recognized organization for scientists involved in basic, applied, and clinical aspects of antiviral research. The Society main event is the annual International Conference on Antiviral Research (ICAR), a truly interdisciplinary meeting which attracts the interest of chemists, biologists, and clinicians.